{"id":"https://openalex.org/W3213036608","doi":"https://doi.org/10.1007/s40266-021-00901-2","title":"A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA","display_name":"A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA","publication_year":2021,"publication_date":"2021-11-08","ids":{"openalex":"https://openalex.org/W3213036608","doi":"https://doi.org/10.1007/s40266-021-00901-2","mag":"3213036608","pmid":"https://pubmed.ncbi.nlm.nih.gov/34746992","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8651576"},"language":"en","primary_location":{"id":"doi:10.1007/s40266-021-00901-2","doi":"https://doi.org/10.1007/s40266-021-00901-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40266-021-00901-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40266-021-00901-2.pdf","source":{"id":"https://openalex.org/S37256505","display_name":"Drugs & Aging","issn_l":"1170-229X","issn":["1170-229X","1179-1969"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs & Aging","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40266-021-00901-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024992400","display_name":"Noll L. Campbell","orcid":"https://orcid.org/0000-0002-8933-9339","observed_orcids":["https://orcid.org/0000-0002-8933-9339"]},"institutions":[{"id":"https://openalex.org/I219193219","display_name":"Purdue University West Lafayette","ror":"https://ror.org/02dqehb95","country_code":"US","type":"education","lineage":["https://openalex.org/I219193219"]},{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noll L. Campbell","raw_affiliation_strings":["Indiana University Center for Aging Research, Indianapolis, IN, USA","Purdue University College of Pharmacy, West Lafayette, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University Center for Aging Research, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I4388446366"]},{"raw_affiliation_string":"Purdue University College of Pharmacy, West Lafayette, IN, USA","institution_ids":["https://openalex.org/I219193219"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109525399","display_name":"Lisa E. Hines","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271158","display_name":"Pharmacy Quality Alliance","ror":"https://ror.org/01zd38g13","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405271158"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Hines","raw_affiliation_strings":["Pharmacy Quality Alliance, Alexandria, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Quality Alliance, Alexandria, VA, USA","institution_ids":["https://openalex.org/I4405271158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073544434","display_name":"Andrew J. Epstein","orcid":"https://orcid.org/0000-0001-5078-6564","observed_orcids":["https://orcid.org/0000-0001-5078-6564"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew J. Epstein","raw_affiliation_strings":["Medicus Economics, Milton, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicus Economics, Milton, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021431857","display_name":"David R Walker","orcid":"https://orcid.org/0000-0001-5113-9123","observed_orcids":["https://orcid.org/0000-0001-5113-9123"]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Walker","raw_affiliation_strings":["Medical Affairs, U.S., Astellas Pharma Global Development, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs, U.S., Astellas Pharma Global Development, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA","institution_ids":["https://openalex.org/I4210165171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016553029","display_name":"Amy Lockefeer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Lockefeer","raw_affiliation_strings":["Medical Affairs, U.S., Astellas Pharma Global Development, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs, U.S., Astellas Pharma Global Development, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA","institution_ids":["https://openalex.org/I4210165171"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107143190","display_name":"Aki Shiozawa","orcid":"https://orcid.org/0000-0001-9757-6337","observed_orcids":["https://orcid.org/0000-0001-9757-6337"]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Aki Shiozawa","raw_affiliation_strings":["Medical Affairs, U.S., Astellas Pharma Global Development, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA. aki.shiozawa@astellas.com","Medical Affairs, U.S., Astellas Pharma Global Development, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA"],"raw_orcid":"https://orcid.org/0000-0001-9757-6337","affiliations":[{"raw_affiliation_string":"Medical Affairs, U.S., Astellas Pharma Global Development, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA. aki.shiozawa@astellas.com","institution_ids":["https://openalex.org/I4210165171"]},{"raw_affiliation_string":"Medical Affairs, U.S., Astellas Pharma Global Development, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA","institution_ids":["https://openalex.org/I4210165171"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5107143190"],"corresponding_institution_ids":["https://openalex.org/I4210165171"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":{"value":3860,"currency":"USD","value_usd":3860},"fwci":1.2468,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.75401929,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"38","issue":"12","first_page":"1075","last_page":"1085"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12246","display_name":"Chronic Disease Management Strategies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/overactive-bladder","display_name":"overactive bladder","score":0.9670000076293945},{"id":"https://openalex.org/keywords/antimuscarinic-agents","display_name":"antimuscarinic agents","score":0.8309999704360962},{"id":"https://openalex.org/keywords/medicare-beneficiaries","display_name":"Medicare beneficiaries","score":0.75},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.8519999980926514},{"id":"https://openalex.org/keywords/falls","display_name":"falls","score":0.6970000267028809},{"id":"https://openalex.org/keywords/fracture","display_name":"fracture","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.6690000295639038},{"id":"https://openalex.org/keywords/healthcare-spending","display_name":"health care spending","score":0.8230000138282776},{"id":"https://openalex.org/keywords/nursing-home-residents","display_name":"nursing home residents","score":0.9829999804496765},{"id":"https://openalex.org/keywords/women","display_name":"women","score":0.48899999260902405}],"concepts":[{"id":"https://openalex.org/C36434225","wikidata":"https://www.wikidata.org/wiki/Q1895998","display_name":"Polypharmacy","level":2,"score":0.9528136849403381},{"id":"https://openalex.org/C2778941218","wikidata":"https://www.wikidata.org/wiki/Q331231","display_name":"Overactive bladder","level":3,"score":0.9284129738807678},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.8889262676239014},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8574230074882507},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5571929216384888},{"id":"https://openalex.org/C2777844464","wikidata":"https://www.wikidata.org/wiki/Q1060922","display_name":"Oxybutynin","level":4,"score":0.5185173749923706},{"id":"https://openalex.org/C2776484012","wikidata":"https://www.wikidata.org/wiki/Q16251540","display_name":"Deprescribing","level":3,"score":0.4856956899166107},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.47679662704467773},{"id":"https://openalex.org/C2776291444","wikidata":"https://www.wikidata.org/wiki/Q6806635","display_name":"Medicare Part D","level":4,"score":0.46788662672042847},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.43934139609336853},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4203932285308838},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3835132420063019},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.2308748960494995},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.1726933717727661},{"id":"https://openalex.org/C2778858636","wikidata":"https://www.wikidata.org/wiki/Q1643563","display_name":"Prescription drug","level":3,"score":0.08631360530853271},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006278","descriptor_name":"Medicare","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018680","descriptor_name":"Cholinergic Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019338","descriptor_name":"Polypharmacy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053201","descriptor_name":"Urinary Bladder, Overactive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D053201","descriptor_name":"Urinary Bladder, Overactive","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s40266-021-00901-2","doi":"https://doi.org/10.1007/s40266-021-00901-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40266-021-00901-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40266-021-00901-2.pdf","source":{"id":"https://openalex.org/S37256505","display_name":"Drugs & Aging","issn_l":"1170-229X","issn":["1170-229X","1179-1969"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs & Aging","raw_type":"journal-article"},{"id":"pmid:34746992","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34746992","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs & aging","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8651576","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8651576/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs Aging","raw_type":"Text"},{"id":"pmh:oai:scholarworks.indianapolis.iu.edu:1805/40165","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1805/40165","pdf_url":"https://scholarworks.indianapolis.iu.edu/bitstreams/7c1f3627-929b-477f-b017-cb4ec41ad0d7/download","source":{"id":"https://openalex.org/S4306400987","display_name":"IUScholarWorks (Indiana University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I592451","host_organization_name":"Indiana University","host_organization_lineage":["https://openalex.org/I592451"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PMC","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1007/s40266-021-00901-2","doi":"https://doi.org/10.1007/s40266-021-00901-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40266-021-00901-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40266-021-00901-2.pdf","source":{"id":"https://openalex.org/S37256505","display_name":"Drugs & Aging","issn_l":"1170-229X","issn":["1170-229X","1179-1969"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs & Aging","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320332563","display_name":"Astellas Pharma Global Development","ror":"https://ror.org/05pw69n24"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3213036608.pdf","grobid_xml":"https://content.openalex.org/works/W3213036608.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1971311909","https://openalex.org/W2021649310","https://openalex.org/W2037164372","https://openalex.org/W2057780602","https://openalex.org/W2058707146","https://openalex.org/W2068451975","https://openalex.org/W2071052332","https://openalex.org/W2131389306","https://openalex.org/W2139337687","https://openalex.org/W2155478022","https://openalex.org/W2168499550","https://openalex.org/W2257575319","https://openalex.org/W2294769571","https://openalex.org/W2413173610","https://openalex.org/W2416611247","https://openalex.org/W2523733773","https://openalex.org/W2529284522","https://openalex.org/W2556613236","https://openalex.org/W2749293303","https://openalex.org/W2755324965","https://openalex.org/W2800521692","https://openalex.org/W2939971450","https://openalex.org/W2944264319","https://openalex.org/W2965564113","https://openalex.org/W3016073506","https://openalex.org/W3037205146","https://openalex.org/W4213351464","https://openalex.org/W4241984066"],"related_works":["https://openalex.org/W4317627227","https://openalex.org/W2970185844","https://openalex.org/W2886986602","https://openalex.org/W4318970085","https://openalex.org/W4414548731","https://openalex.org/W4417035594","https://openalex.org/W2092298958","https://openalex.org/W2944264319","https://openalex.org/W4386541382","https://openalex.org/W4378211452"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"OBJECTIVE:":[2],"Antimuscarinics,":[3],"drugs":[4],"with":[5,19,69,93,116,162,223,237,253],"anticholinergic":[6,15,61,137,146,205,261],"properties,":[7],"are":[8],"frequently":[9],"prescribed":[10],"for":[11,47,127],"overactive":[12,70,94,177,238],"bladder,":[13],"and":[14,41,49,72,77,81,151,156,192,197,245,249],"burden":[16],"is":[17,42],"associated":[18,222,252],"adverse":[20],"events.":[21],"The":[22,180],"\"Polypharmacy:":[23],"Use":[24],"of":[25,60,90,110,125,136,174,182,204,212,226,260],"Multiple":[26],"Anticholinergic":[27,99,230],"Medications":[28],"in":[29,66,133,190,194,216],"Older":[30],"Adults\"":[31],"(Poly-ACH)":[32],"measure":[33],"was":[34,85,105,139,188,221,232,241,251],"developed":[35],"by":[36,44,102],"the":[37,45,53,58,67,103,185,217],"Pharmacy":[38],"Quality":[39],"Alliance":[40],"used":[43],"Centers":[46],"Medicare":[48,64,91],"Medicaid":[50],"Services.":[51],"Using":[52],"Poly-ACH":[54,186,214],"measure,":[55],"we":[56],"assessed":[57,140,161],"prevalence":[59],"polypharmacy":[62,76,138,147,231],"among":[63,234,243],"patients":[65,170,183],"USA":[68],"bladder":[71,95,178],"determined":[73],"associations":[74],"between":[75,145],"medical":[78,157],"conditions,":[79],"care,":[80],"spending.":[82],"METHODS:":[83],"This":[84],"a":[86],"retrospective":[87],"cohort":[88],"study":[89],"beneficiaries":[92],"(coverage":[96],"period:":[97],"2006-2017).":[98],"polypharmacy,":[100],"measured":[101],"Poly-ACH,":[104],"defined":[106],"as":[107],"concurrent":[108],"use":[109],"two":[111,117],"or":[112,118,210],"more":[113,119,211],"anticholinergics,":[114],"each":[115],"prescription":[120],"claims":[121],"on":[122],"different":[123],"dates":[124],"service":[126],"\u2265":[128],"30":[129],"cumulative":[130],"days.":[131],"Change":[132],"annual":[134],"frequency":[135],"using":[141],"logistic":[142],"regression.":[143],"Associations":[144],"over":[148],"3":[149,218],"years":[150,219],"falls,":[152],"fractures,":[153],"mental":[154],"status,":[155],"care":[158],"spending":[159],"were":[160],"longitudinal":[163,258],"regression":[164],"models.":[165],"RESULTS:":[166],"In":[167],"total,":[168],"226,712":[169],"contributed":[171],"940,201":[172],"person-years":[173],"follow-up":[175],"after":[176],"diagnosis.":[179],"share":[181],"meeting":[184],"definition":[187],"3.3%":[189],"2006":[191],"1.7%":[193],"2017.":[195],"Women":[196],"nursing":[198,246],"home":[199,247],"residents":[200],"had":[201],"higher":[202,224,242],"risks":[203],"polypharmacy.":[206],"Having":[207],"1":[208],"year":[209],"positive":[213],"status":[215],"prior":[220],"rates":[225],"all":[227],"outcomes.":[228],"CONCLUSIONS:":[229],"uncommon":[233],"older":[235],"adults":[236],"bladder.":[239],"Prevalence":[240],"women":[244],"residents,":[248],"it":[250],"negative":[254],"outcomes,":[255],"highlighting":[256],"potential":[257],"implications":[259],"burden.":[262]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2021-11-22T00:00:00"}